Molecular Pathology of Cancer
The Molecular Pathology of Cancer Research Unit, previously known as Cancer Epigenetics Unit, includes researchers from Navarrabiomed and clinical researchers from the Anatomical Pathology, Surgery and Neurosurgery Services at the Navarra Hospital Complex. Its main goal is to identify new biomarkers for prognosis and response to treatment in patients with different types of cancer: breast, gynaecological and brain tumours, among others.
This Unit works with other research groups at Navarrabiomed (Oncoimmunology, Oncobiona Tras), the Radiation Oncology Team at CHN, groups from other organisations (IUOPA in Oviedo, PEBC-IDIBELL in Barcelona), and technology platforms at Navarrabiomed, the National Cancer Research Centre (CNIO in Madrid) and the Biomedical Research Centre of La Rioja (CIBIR in Logroño).
Lines of research:
- Identification of microRNAs and of hypermethylation in the tumour suppressor genes involved in solid tumour progression.
- Analysis of prognostic value and predicted response to cancer treatment in solid tumour biomarkers.
- Analysis of protein expression profiles as related to tumour characteristics.
- In vitro functional assays.
Navarrabiomed - Centro de investigación biomédica
Complejo Hospitalario de Navarra, edificio de investigación.
Calle Irunlarrea, 3. 31008 Pamplona, Navarra, España.